Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Pfizer Inc (PFE)
Price$28.67Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.58B | $63.63B | $50.91B | $91.79B | $73.64B | $41.65B | $40.91B | $40.83B | $52.55B | $52.82B | $48.85B | $49.60B | $51.58B | $54.66B | $61.03B | $65.17B | $49.27B | $48.30B | $48.42B |
| Gross profit | $46.51B | $45.78B | $25.96B | $57.45B | $42.81B | $33.17B | $32.85B | $31.84B | $41.32B | $40.50B | $39.20B | $40.03B | $42.00B | $44.84B | $48.53B | $50.38B | $40.81B | $40.18B | $37.18B |
| Gross margin | 74.33% | 71.94% | 50.99% | 62.59% | 58.14% | 79.63% | 80.31% | 77.99% | 78.63% | 76.67% | 80.25% | 80.69% | 81.42% | 82.03% | 79.52% | 77.31% | 82.83% | 83.20% | 76.79% |
| Research & development | $10.44B | $10.82B | $10.68B | $11.43B | $10.36B | $8.71B | $8.38B | $7.76B | $7.68B | $7.89B | $7.69B | $8.39B | $6.68B | $7.48B | $8.68B | $9.48B | $7.82B | $7.95B | $8.09B |
| Operating expenses | $29.11B | $30.84B | $30.18B | $28.71B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $17.41B | $14.94B | $4.42B | $38.12B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 27.82% | 23.48% | 8.68% | 41.52% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $16.78B | $18.13B | $9.56B | $41.03B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA margin | 26.82% | 28.49% | 18.77% | 44.70% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | $21.31B | $7.21B | $6.96B | $9.13B | $22.00B | $14.57B | $10.01B | $8.26B | $8.63B | $8.10B | $8.14B |
| Net profit margin | 12.42% | 12.62% | 4.16% | 34.18% | 29.85% | 21.99% | 39.18% | 27.32% | 40.55% | 13.66% | 14.25% | 18.42% | 42.65% | 26.66% | 16.40% | 12.67% | 17.53% | 16.78% | 16.82% |
| Basic EPSper basic share | $1.37 | $1.42 | $0.38 | $5.59 | $3.92 | $1.65 | $2.88 | $1.90 | $3.57 | $1.18 | $1.13 | $1.44 | $3.23 | $1.96 | $1.28 | $1.03 | $1.23 | $1.20 | $1.18 |
| Diluted EPSper diluted share | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.63 | $2.82 | $1.87 | $3.52 | $1.17 | $1.11 | $1.42 | $3.19 | $1.94 | $1.27 | $1.02 | $1.23 | $1.20 | $1.17 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
BlackRock, Inc. | 529.67M |
VANGUARD CAPITAL MANAGEMENT LLC | 372.15M |
STATE STREET CORP | 307.09M |
GEODE CAPITAL MANAGEMENT, LLC | 135.28M |
VANGUARD PORTFOLIO MANAGEMENT LLC | 119.24M |
Fisher Asset Management, LLC | 109.07M |
MORGAN STANLEY | 96.35M |
NORGES BANK | 61.51M |
NORTHERN TRUST CORP | 59.08M |
Bank of New York Mellon Corp | 57.88M |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 56.55M |
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 54.51M |
GOLDMAN SACHS GROUP INC | 52.99M |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 52.55M |
BANK OF AMERICA CORP /DE/ | 43.59M |
Legal & General Group Plc | 43.23M |
DIMENSIONAL FUND ADVISORS LP | 38.06M |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 36.16M |
Amundi | 33.53M |
ROYAL BANK OF CANADA | 32.81M |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 9, 2026Form 4 | DAMICO JENNIFER B.SVP & Controller | SellCommon Stock | 2.0K | $25.70 | $51.4K | 31.4K |
| Mar 4, 2025Form 4 | DAMICO JENNIFER B.SVP & Controller | SellCommon Stock | 2.5K | $25.93 | $64.8K | 11.8K |
| Feb 13, 2025Form 4 | BLAYLOCK RONALD EDirector | BuyCommon Stock | 19.5K | $25.65 | $499.1K | 27.7K |
| Oct 30, 2024Form 4 | Gottlieb ScottDirector | BuyCommon Stock | 1.0K | $28.24 | $28.2K | 10.0K |
| Aug 13, 2024Form 4 | DAMICO JENNIFER B.SVP & Controller | SellCommon Stock | 5.2K | $28.66 | $147.7K | 8.6K |